DigiPath Labs, the cannabis testing subsidiary of DigiPath, Inc. (DIGP), today announced that its medical marijuana safety and potency testing services are generating revenue as medical marijuana dispensaries open in Nevada. The company’s Las Vegas testing facility is now testing cannabis products for a growing number of cultivators, cannabis-infused product makers, and even other cannabis testing labs.

“We’ve been working on our diversification strategy since April, 2014, and now our investments in cannabis testing are starting to pay off,” said Todd Denkin, DigiPath Labs’ CEO. “We’ve reached a turning point that will benefit our investors and medical marijuana patients all over the state.”

Over the last year, Denkin helped DigiPath, Inc., diversify from a global digital pathology solution provider into the burgeoning American cannabis industry. Its DigiPath Labs subsidiary now offers full-service, independent cannabis testing and consulting in the State of Nevada. “We decided to equip the lab with the best and most robust analytical instruments on the market in order to perform as many as 100 tests per day and deliver results in only 48 hours,” said Denkin.

DigiPath purposely chose to build its flagship testing lab in Nevada, the state with the most stringent testing requirements in the nation. The company is also working to establish labs in other states where cannabis is legal. These labs will be based upon the model it created in Las Vegas, which Denkin believes has set the gold standard for cannabis labs.

Las Vegas stands to become one of the largest medical marijuana markets in the country since Nevada allows dispensaries to sell marijuana to patients from other states as long as they possess a medical cannabis card or doctor’s recommendation. To serve the residents and the 42 million visitors who come here every year, The Nevada Division of Public and Behavioral Health estimates the demand for cannabis next year will be 459 thousand pounds, all of which will be subject to Nevada’s testing requirements prior to sale.

State voters, including 118,537 current cannabis users, will vote on legalizing recreational marijuana use in November, 2016. If passed, it could create a cannabis market between $150 million and $300 million in sales, factoring in sales to tourists, according to the financial education publication NerdWallet.

For more information about DigiPath Labs, go to http://digipathlabs.com.

About DigiPath, Inc. (DIGP)
DigiPath, Inc., supports the cannabis industry’s best practices for reliable testing, education, and training, and brings unbiased cannabis news coverage to the nation. DigiPath’s three business units are DigiPath Labs, TNM News Corp., and DigiPath Corp. For more information about DigiPath Labs, go to http://digipath.com or call 702-470-2249.

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.